Acta Psychiatr Scand

1. BAEZA I, Tor J, de la Serna E, Sugranyes G, et al
   Impact of Obstetric Complications in Subjects at Clinical High Risk for Psychosis: A Systematic Review and Meta-Analysis.
   Acta Psychiatr Scand. 2025;152:81-93.
   

   >> Share

   
   

   
   J Clin Psychiatry

2. KUMAR N, Prasad S, Srivastava MVP, Kalaivani M, et al
   Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia: A Double-Blind Sham-Controlled Study.
   J Clin Psychiatry. 2026;87:25m16093.
   

   >> Share

   
   
3. CITROME L, Bell Lynum KS, Zhang Z, Atkins N Jr, et al
   Aripiprazole Once-Monthly for Patients Diagnosed With Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
   J Clin Psychiatry. 2026;87:26m16359.
   

   >> Share

   
   

   
   J Psychiatry Neurosci

4. HAN Y, Du Y, Xia Y, Hua L, et al
   Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification.
   J Psychiatry Neurosci. 2026;51:1-14.
   

   >> Share

   
   

   
   Mol Psychiatry

5. BARENDSE MEA, Poortman SR, Ching CRK, Cahn W, et al
   White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis.
   Mol Psychiatry. 2026 May 21. doi: 10.1038/s41380-026-03628.
   

   >> Share

   
   
6. OWEN MJ, O'Donovan MC
   Rethinking schizophrenia: insights from genomics and implications for research.
   Mol Psychiatry. 2026 May 21. doi: 10.1038/s41380-026-03654.
   

   >> Share

   
   
7. NERLAND S, Barth C, Jorgensen KN, Wortinger LA, et al
   Cerebral cortical alterations in adolescent early-onset psychosis: a surface-based morphometry mega-analysis.
   Mol Psychiatry. 2026 May 19. doi: 10.1038/s41380-026-03641.
   

   >> Share

   
   
8. LUTHER L, Cooper JA, Treadway MT, Knippenberg AR, et al
   Computational phenotypes underlying effort-based decision-making and negative symptoms in a transdiagnostic severe mental illness sample.
   Mol Psychiatry. 2026;31:3435-3445.
   

   >> Share

   
   
9. XUE H, Lei M, Zhao Q, Zhang Z, et al
   Powering the mind: deciphering the shared genetic architecture between mitochondrial DNA copy number and major psychiatric disorders.
   Mol Psychiatry. 2026;31:3127-3138.
   

   >> Share

   
   

   
   Pharmacopsychiatry

10. HART XM, Hirjak D, Eap CB, Eichentopf L, et al
    High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting.
    Pharmacopsychiatry. 2026 May 20. doi: 10.1055/a-2868-3000.
    

    >> Share

    
    

    
    PLoS One

11. FENG Y, Wang Y, Wang B
    An exploratory study on cortical hemodynamics and handgrip strength phenotypes in long-term hospitalized patients with stable schizophrenia.
    PLoS One. 2026;21:e0349442.
    

    >> Share

    
    

    
    Psychiatry Res

12. YANG Y, Zhu Y, Wu R, Jiang F, et al
    Short-term development of neurocognition in early-stage schizophrenia with predominant negative symptoms.
    Psychiatry Res. 2026;363:117230.
    

    >> Share

    
    

    
    Schizophr Res

13. STRAUSS GP, Zhang Z, Arnold LE, Hutcheson AL, et al
    Subjective perceptions of negative symptoms among outpatients with schizophrenia and their relatives or caregivers: Definitions, importance, measurement, and desired improvement.
    Schizophr Res. 2026;295:61-71.
    

    >> Share

    
    
14. FOO CYS, Leonard CJ, McLaughlin MM, Johnson KA, et al
    A mixed methods study of program-level factors influencing patient and family engagement in first episode psychosis coordinated specialty care.
    Schizophr Res. 2026;295:52-60.
    

    >> Share

    
    
15. SUN L, Bo Y, Li D, Yao P, et al
    Plasma metabolomic signature of frailty and risk of late-onset schizophrenia: A prospective cohort study.
    Schizophr Res. 2026;295:29-38.
    

    >> Share

    
    
16. WANG J, Yang M, Wang Z, Xue K, et al
    Changes in neurovascular coupling of cerebral blood flow and functional connectivity strength in first-episode schizophrenia patients after antipsychotic treatment.
    Schizophr Res. 2026;295:11-20.
    

    >> Share

    
    
17. RICH HM, Pokorny VJ, Osborne KJ, Geiger M, et al
    Atypical semantic priming in individuals at clinical risk for psychosis.
    Schizophr Res. 2026;295:3-10.
    

    >> Share

    
    
18. IGARASHI Y, Norii T, Ohno E, Wakisaka R, et al
    Foreign body airway obstruction in schizophrenia: Findings from a prospective multicenter registry.
    Schizophr Res. 2026;295:1-2.
    

    >> Share

    
    
19. KIRPINAR MM, Aksoy Poyraz C, Yildirim I, Polat CD, et al
    Predictors of early discontinuation of clozapine under rapid titration in a Turkish tertiary inpatient setting.
    Schizophr Res. 2026;293:8-16.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share